We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+28.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$24.2M
Cap. Flow
+$3.94M
Cap. Flow %
1.45%
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
37
Reduced
82
Closed
24

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.52M
2
ROK icon
Rockwell Automation
ROK
+$4.16M
3
NEM icon
Newmont
NEM
+$3.45M
4
EMR icon
Emerson Electric
EMR
+$3.41M
5
MSFT icon
Microsoft
MSFT
+$2.94M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.32M
2
FCX icon
Freeport-McMoran
FCX
+$3.32M
3
CTVA icon
Corteva
CTVA
+$3.26M
4
DVN icon
Devon Energy
DVN
+$3.24M
5
UNH icon
UnitedHealth
UNH
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.6%
2 Healthcare 22.77%
3 Financials 8.72%
4 Energy 6.58%
5 Consumer Staples 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
176
iShares Russell 2000 ETF
IWM
$83.1B
-1,639
Closed -$292K
KSS icon
177
Kohl's
KSS
$2.22B
-31,300
Closed -$737K
KURA icon
178
Kura Oncology
KURA
$851M
-13,443
Closed -$164K
PENN icon
179
PENN Entertainment
PENN
$2.71B
-7,455
Closed -$221K
SAIA icon
180
Saia
SAIA
$9.76B
-1,560
Closed -$424K
SONO icon
181
Sonos
SONO
$1.85B
-12,493
Closed -$245K
SPOK icon
182
Spok Holdings
SPOK
$240M
-18,312
Closed -$186K
VYM icon
183
Vanguard High Dividend Yield ETF
VYM
$82.7B
-1,989
Closed -$210K
NXGN
184
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-13,278
Closed -$231K
NEWR
185
DELISTED
New Relic, Inc.
NEWR
-4,913
Closed -$370K
ABB
186
DELISTED
ABB Ltd
ABB
-27,111
Closed -$930K

Similar funds

Innovis Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Innovis Asset Management held 186 positions worth $271M, up 9.8% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q2 2023 filing shows 25 new, 37 increased, 82 reduced and 24 closed positions. Its largest new stake was DexCom: 37,345 shares worth $4.8M. The largest sale was Pfizer, an estimated $5.32M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q2 2023 buy was DexCom: 37,345 shares worth $4.8M.
  • Innovis Asset Management added most to Newmont in Q2 2023, an estimated $3.45M increase.
  • Innovis Asset Management's biggest Q2 2023 reduction was Pfizer, cutting an estimated $5.32M.
  • Innovis Asset Management fully exited Freeport-McMoran in Q2 2023, selling an estimated $3.32M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $271M portfolio in Q2 2023.
  • Innovis Asset Management opened 25 new positions and closed 24 in Q2 2023.
  • Innovis Asset Management's portfolio value rose 9.8% quarter-over-quarter to $271M.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.